«Studies should continue to compare vaccine effectiveness before and after sexual debut and by
vaccine doses received and to explore the role of herd immunity,» added Perkins.
Not exact matches
To prevent your child from getting rotavirus (which can cause diarrhea, vomiting, and fever, especially in babies and young children), your baby should
receive two or three
doses of the rotavirus
vaccine, depending on which version of the
vaccine your doctor recommends.
Adolescents who
receive their two shots less than five months apart will require a third
dose of HPV
vaccine.»
Infants don't
receive their first
dose of the flu
vaccine until they are at least 6 months old.
Your doctor will arrange for your child to
receive 1 or 2 more
doses of the
vaccine, if needed, over the next few months.
If your child is under age 9 and
receiving the flu shot or nasal spray
vaccine for the first time, it's recommended that he get two
doses at least four weeks apart.
At about six months of age, your baby should
receive third
doses of the following
vaccines: DTaP, Hib, pneumococcal and rotavirus.
They should also
receive their first
dose of haemophilus influenza and pneumococcal conjugate
vaccine.
«Public confidence in the MMR
vaccine continues to remain high as the uptake for those
receiving their first
dose has stayed stable.
He said his office has
received delivery of 90,500
doses of
vaccine for the exercise which would cover the 11 electoral wards in the area.
That year, 98 percent of Mexicans and 92 percent of Americans
received at least one
dose of
vaccine, the World Health Organization and UNICEF estimate.
In a clinical trial, this
vaccine protected 45 percent of the adults who
received the highest
dose against infection from H5N1.
During a pertussis outbreak in 2010 — 11 in California teens who had
received four
doses of the current
vaccine were at almost six times more likely to get pertussis as those who had
received four
doses of the older preparation.
In our study, for every 83 individuals
receiving the high
dose vaccine a person was prevented from being hospitalized during the influenza season,» he said.
The group that
received the high
dose vaccine had a 19.7 percent hospital admission rate versus 20.9 percent in admission for those who
received the standard
dose vaccine.
Children undervaccinated for three or four
doses of DTaP
vaccine were 18.56 and 28.38 times more likely, respectively, to have
received a diagnosis of pertussis than children who were age - appropriately vaccinated, the study reports.
She
received 28
doses of her personalized
vaccine over a two - year period, and thereafter remained disease - free for five years.
Guidelines recommend that adolescents and adults ages 11 and up
receive a single
dose of the Tdap
vaccine for booster immunization even if they have had a Td (tetanus and diphtheria)
vaccine within the past 10 years.
And yet, newborns don't
receive their first
dose of DTaP (the pediatric
vaccine for pertussis and two other diseases) until they are two months old and aren't fully protected until they are six months old.
Members of the other group
received an HPV
vaccine - specific brochure, plus telephone calls to parents who declined, and reminder calls to patients overdue for the second and third
doses of the
vaccine.
CDC based its decision for children under 10 to
receive two
doses on preliminary data from clinical trials of the
vaccines being used in the United States, but he said more complete data should emerge soon.
After the European Medicines Agency's Committee for Medicinal Products for Human Use meeting 19 - 22 October, the agency recommended that everyone regardless of age
receive two
doses of the pandemic flu
vaccines approved for use there.
The World Health Organization is working to increase the percentage of infants who
receive at least three
doses of pertussis
vaccine to 90 percent or higher, especially in developing countries.
At the end of the trial, those who
received the high -
dose vaccine scored an average of 39 percent lower on symptoms and medication use than did those who got the dummy shots.
The Centers for Disease Control and Prevention (CDC) recommend girls and boys ages 11 and 12
receive three
doses of an HPV
vaccine.
Each subject
received six weekly injections with either a placebo or one of two
doses of active
vaccine.
In each year, 53 percent of the girls had
received at least one
dose of HPV
vaccine and were said to have initiated vaccination.
Tested in a U.S. - sponsored trial that involved more than 16,000 volunteers in Thailand, the
vaccine was administered in six injected
doses starting in 2006 to half of the group, and the other half
received a placebo.
In tests in mice, animals that
received a single
dose of one of the
vaccines showed no symptoms following exposure to the real pathogen — Ebola, H1N1 influenza, or Toxoplasma gondii.
As part of the study, groups of 18 to 20 female mice were vaccinated with one of the
vaccines or a placebo, and some animals
received a second
dose of the same
vaccine or placebo a month later.
Preliminary evidence suggested that the
vaccine wards off disease; none of the patients who
received the
vaccine developed influenza in the winter after they were vaccinated, compared to two in a group who
received a lower
dose, and seven in the placebo group, the team reports today in the Journal of the American Medical Association.
The best immune response was shown in a group of nine test persons who
received the highest
dose of the
vaccine three times at four - week intervals.
Healthy females (age stratified: 9 - 14, 15 - 19, 20 - 25 years) were randomized to
receive two
doses of
vaccine at months 0 and 6, or three
doses of the
vaccine at months 0, 1, and 6.
The authors cite barriers to adoption of the HPV
vaccine in boys that include the misconception that HPV is only a women's health issue, not
receiving a recommendation from a doctor or health care provider, and concerns over costs; in provinces where the HPV
vaccine is not provided free, the cost of one
dose is about $ 150, and multiple
doses are required.
But the Congolese government, worried that the virus could spread rapidly among Kinshasa's 10 million residents, has decided to stretch the 1.7 million
doses it has
received by giving people 0.1 milliliters of the
vaccine each instead of the standard 0.5 milliliters.
A single
dose of either of two experimental Zika
vaccines fully protected mice challenged with Zika virus four or eight weeks after
receiving the inoculations.
But the levels of antibodies that the high -
dose volunteers generated were in line with those seen in monkeys that were protected from Ebola after
receiving the same
vaccine, Fauci says.
In the trial of the bivalent
vaccine, volunteers
received one of two
doses.
Among the latter group, about 46 out of every thousand were hospitalized per year of observation; among those who had
received a
dose of anthrax
vaccine, that number was only 25 — a statistically significant difference.
But volunteers who
received the high
dose of the
vaccine made more antibodies against the Zaire - Guinea strain than did those who
received a lower
dose.
Volunteers who
received a high
dose of the
vaccine had, on average, higher antibody levels than people who
received a lower
dose.
Further trials are planned for Switzerland, Mali, and Uganda; Ballou says altogether about 150 volunteers will
receive the single -
dose vaccine.
Influenza
vaccine coverage overall is low among young children and those in need of two
doses in a given season are at particular risk, with less than half of those who
receive the first
dose returning to
receive the second needed
doses.
The results showed that children in the educational text message reminder group were significantly more likely to
receive a second
dose of influenza
vaccine (72.7 %) than both those in the conventional text message reminder group (66.7 %) and written reminder - only group (57.1 %).
Participants
received oral BivWC
vaccine on days 0 and 14 (following the recommended regimen of two
doses 14 days apart), and the researchers drew blood at day 0, and at 7 days following each
vaccine dose (days 7 and 21).
In the study, mice given a lethal
dose of dengue virus less than a week after
receiving the protective DMAb were completely protected from lethal disease — significantly more rapid than
vaccine - driven protection, which can take weeks to months to reach peak efficacy levels.
Volunteers
received either one or two
doses of the candidate live attenuated
vaccine and then 12 weeks later
received an inactivated H7N9
vaccine, manufactured by Sanofi Pasteur (Swiftwater, Pennsylvania).
The live attenuated
vaccine primer created strong immune memory in both age groups, regardless of whether volunteers
received one or two
doses.
Each patient
received an average of six
doses of the HSPPC - 96
vaccine.
Although the
vaccine produces an immune response in volunteers who
receive the shots, it must be given in two large
doses.